Effects of Non Contact Low Frequency Ultrasound in Healing Venous Leg Ulcers (NCT01549860) | Clinical Trial Compass
CompletedNot Applicable
Effects of Non Contact Low Frequency Ultrasound in Healing Venous Leg Ulcers
United States156 participantsStarted 2012-04
Plain-language summary
This trial is a prospective, randomized, controlled, multi-center study of subjects presenting with chronic lower extremity venous ulcers. The study will evaluate the safety and effectiveness of MIST Therapy® plus standard of care (MIST+SOC) compared to Standard of Care (SOC) alone in the treatment of lower extremity venous ulcers.
Who can participate
Age range
18 Years – 90 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Lower extremity full thickness venous ulcer of \> 30 days duration
* Subject's wound must be between 4 cm² and 50 cm² at screening
* Documented ABI that is between 0.8 and 1.2 on the study limb or transcutaneous partial pressure oxygen (TcpO2) \> 40 mmHG; or a toe pressure \> 40 mmHG; or a Doppler waveform consistent with adequate flow in the foot (biphasic or triphasic waveforms) at time of screening
* Biopsy for wounds \> 6 months duration
* Documented index wound etiology of venous stasis with reflux and /or incompetent valves
Exclusion Criteria:
* Index ulcer wound that is less than 1 cm in distance from another ulcer wound
* \> 5 ulcers on the index leg
* Index ulcer wound has exposed tendons, ligaments, muscle, or bone
* Index ulcer wound presents with clinical signs of acute infection, suspected or known
* Subjects with evidence of osteomyelitis or cellulitis or gangrene in the study limb
* Subjects with amputation above a Trans Metatarsal Amputation (TMA) in the study limb
* Subjects with active malignancy on the study limb except non-melanoma skin cancer
* Index ulcer that is of arterial disease etiology
* Index ulcer of other primary etiology (ie. vasculitis, arterial, pyoderma)
* Subjects with planned vascular surgery, angioplasty or thrombolysis procedures within the study treatment phase
* Subjects with planned surgical procedure during the study treatment phase for the index wound including skin flap or skin graft
* Subjects within 6 wee…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Wound Area Mean Percent Reduction
Timeframe: 4 weeks post baseline visit (randomization visit)